110 related articles for article (PubMed ID: 7567689)
1. Ret-oncogene expression correlates with neuronal differentiation of neuroblastic tumors.
Ikuno N; Shimokawa I; Nakamura T; Ishizaka Y; Ikeda T
Pathol Res Pract; 1995 Mar; 191(2):92-9. PubMed ID: 7567689
[TBL] [Abstract][Full Text] [Related]
2. Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.
Powers JF; Brachold JM; Tischler AS
Endocr Pathol; 2003; 14(4):351-61. PubMed ID: 14739491
[TBL] [Abstract][Full Text] [Related]
3. Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin.
Nakamura T; Ishizaka Y; Nagao M; Hara M; Ishikawa T
J Pathol; 1994 Mar; 172(3):255-60. PubMed ID: 8195928
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
Iwamoto T; Taniguchi M; Wajjwalku W; Nakashima I; Takahashi M
Br J Cancer; 1993 Mar; 67(3):504-7. PubMed ID: 8439501
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer.
Dawson DM; Lawrence EG; MacLennan GT; Amini SB; Kung HJ; Robinson D; Resnick MI; Kursh ED; Pretlow TP; Pretlow TG
J Natl Cancer Inst; 1998 Apr; 90(7):519-23. PubMed ID: 9539247
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ret-, p75(NTR)-, Phox2a-, Phox2b-, and tyrosine hydroxylase-immunoreactivity by undifferentiated neural crest-derived cells and different classes of enteric neurons in the embryonic mouse gut.
Young HM; Ciampoli D; Hsuan J; Canty AJ
Dev Dyn; 1999 Oct; 216(2):137-52. PubMed ID: 10536054
[TBL] [Abstract][Full Text] [Related]
8. Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis.
Bunone G; Borrello MG; Picetti R; Bongarzone I; Peverali FA; de Franciscis V; Della Valle G; Pierotti MA
Exp Cell Res; 1995 Mar; 217(1):92-9. PubMed ID: 7867726
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical diagnosis of papillary thyroid carcinoma.
Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
[TBL] [Abstract][Full Text] [Related]
10. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
11. Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells.
Takahashi M; Buma Y; Taniguchi M
Oncogene; 1991 Feb; 6(2):297-301. PubMed ID: 2000222
[TBL] [Abstract][Full Text] [Related]
12. Divergent differentiation in neuroendocrine tumors of the adrenal gland.
Tischler AS
Semin Diagn Pathol; 2000 May; 17(2):120-6. PubMed ID: 10839612
[TBL] [Abstract][Full Text] [Related]
13. Detection of phosphorylated retTPC oncogene product in cytoplasm.
Ishizaka Y; Shima H; Sugimura T; Nagao M
Oncogene; 1992 Jul; 7(7):1441-4. PubMed ID: 1620555
[TBL] [Abstract][Full Text] [Related]
14. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
15. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
16. [Involvement of proto-ret and activated ret in human malignancy].
Ishizaka Y; Tahira T; Ushijima T; Ito F; Nagao M
Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1391-9. PubMed ID: 1871359
[No Abstract] [Full Text] [Related]
17. Acquisition of neuronal and glial markers by neural crest-derived cells in the mouse intestine.
Young HM; Bergner AJ; Müller T
J Comp Neurol; 2003 Jan; 456(1):1-11. PubMed ID: 12508309
[TBL] [Abstract][Full Text] [Related]
18. Expression of endothelin system in neuroblastic tumors: close association of endothelin-1 and endothelin B receptor expression with differentiation of tumor cells.
Hoshi N; Sugino T; Suzuki T
Med Mol Morphol; 2009 Jun; 42(2):110-7. PubMed ID: 19536618
[TBL] [Abstract][Full Text] [Related]
19. Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.
Ikeda I; Ishizaka Y; Tahira T; Suzuki T; Onda M; Sugimura T; Nagao M
Oncogene; 1990 Sep; 5(9):1291-6. PubMed ID: 2216455
[TBL] [Abstract][Full Text] [Related]
20. High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.
Monferrer E; Burgos-Panadero R; Blanquer-Maceiras M; Cañete A; Navarro S; Noguera R
BMC Cancer; 2019 Jan; 19(1):1. PubMed ID: 30606139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
